Mike Nolte, CEO talks about Signant’s new brand and the importance of bringing empathy into clinical trials at DIA 2019 with PharmaVOICE.
Signant Health Launches CRO Partner Program
The Signant Health Partner Program enables CROs to better serve sponsors in the areas of Patient Data, Pati...
Other content in this Stream
Selecting and Implementing Mobile Sensors to Collect Clinical Trial Endpoint Data
In this webinar learn how to select a device that is acceptable to regulators and patients, implement mobile sensors appropriately within study protocols, and interpret the data they provide.
Building Patient Engagement and Secure Drug Discovery - Data Privacy, Compliance, and Security
Much has been made of the trials and tribulations of complying with data regulations; however, Paul Drake from Signant argues there may be significant opportunities to be gained from data compliance
Signant Health finds growing eConsent adoption forecasts and the importance of eClinical integration in latest “State of eConsent” survey
Signant Health released the findings from its latest “State of eConsent” report, highlighting the sentiments, successes, and challenges of electronic informed consent practitioners around the world.
Delving into eConsent: Industry Survey Reinforces Patient Centricity
Signant conducted an electronic informed consent (eConsent) survey to obtain insights from sponsors and CROs. Here are the findings from this key piece of research
PharmaVoice - Leveraging Virtual Technology to Improve Processes
In this issue of PharmaVoice, Signant Health's Bill Byrom shares his viewpoint of the potential of virtual health.
Signant Health Partners with Propeller Health to Gather Accurate Data on Asthma and COPD Medication Use
Signant’s TrialMax® eCOA platform and Propeller Health’s digital health platform connect to improve patient engagement and simplify data collection using real-time management and dose tracking.
Signant Health Joins the Association of Clinical Research Organizations to Add a Technology Perspective on the Future of Clinical Research
As the 13th member company elected into Association of Clinical Research Organizations, Signant Health brings our unique voice and views on patient-centricity and trial technology to the forefront
Simplify clinical trial activity and sleep monitoring for patients, sites, and sponsors with ActiGraph integration
The integration of Signant Health’s TrialMax® eCOA platform with ActiGraph’s CentrePoint system and research-grade wearables marries ease-of-use with real-time data and insights
Signant Health's eCOA and Endpoint Quality Solutions for Orphan Disease Research
Signant Health provides a complete eCOA and Endpoint Quality solution that is user-friendly & allows you to capture data on clinician & patient-rated outcome measures & event diaries, on-site or home
Signant Health Raises the Bar in Ulcerative Colitis Trials with eCOA
Q&A with Katie Garner, Signant Health: Using eCOA in Ulcerative Colitis Trials for Seamless MAYO Score Calculation
Signant Health Hosts 8th Annual eCOA Forum
Signant Health hosts 8th annual eCOA Forum, Dec 10-11, 2019 in Philadelphia.
Signant Health Sponsors and Presents at CNS Summit 2019
Signant Health Sponsors and Presents at CNS Summit 2019.
Patient-Facing Technologies in Clinical Research: Myths vs. Reality
This webinar explores misconceptions surrounding technologies like eConsent and BYOD ePRO with industry experts, helping you make informed decisions and improve your clinical trial success.
The University of Bristol Selects Signant Health's TrialConsent Solution in Oncology Trial
The Prestigious UK Academic Institution selected TrialConsent® to Administer eConsent to Benefit Sites and Patients in Future Clinical Research.
Get to Know TrialMax eCOA - Signant Health
When it comes to eCOA – the patient experience matters. Watch this video to learn more about TrialMax.
Signant Health Sponsors Rare Disease Film Festival
Signant Health is proud to sponsor Disorder: The Rare Disease Film Festival (RDFF).
Signant Selected as eConsent Provider by Shanghai Mental Health Center
Signant Health has been selected to provide eConsent for a significant neuroscience study by the prestigious Shanghai Mental Health Center (SMHC).
Bill Byrom Welcomes You to the 2019 eCOA Forum
Bill Byrom welcomes you to the 2019 eCOA Forum. Join us Dec 10-11, 2019 in Philadelphia.
Signant Health's Endpoint Quality Solution
Signant Health’s Endpoint Quality solution offers a comprehensive array of evidence-based services to ensure the accuracy and precision of clinical trial endpoint data across a variety of therapeutic
Signant Health Appoints Todd Everhart as Clinical Vice President